Skip to main content

Medicines labeled for the same conditions

Alternatives to gemfibrozil

19 other medicines are given the same way (oral) and in the same FDA class as gemfibrozil or labeled mainly for the same use (high cholesterol); 2 are in its class, peroxisome proliferator receptor alpha agonists: fenofibrate and fenofibric acid; the others include 7 HMG-CoA reductase inhibitors, 3 bile acid sequestrants and 2 dietary cholesterol absorption inhibitors (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $0.103 per fenofibrate 160 mg tablet (what pharmacies paid in the NADAC survey; strengths differ).

Which medicines are labeled for the same conditions as gemfibrozil?

High cholesterol lists all 25 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.

Medicine and FDA classShared indicationGeneric labelers (oral)Pharmacy costBoxed warningShortage
Gemfibrozilperoxisome proliferator receptor alpha agonistthis medicine27 labelers$0.104 per tablet 600 mg tabletYesA presentation being discontinued
Fenofibrateperoxisome proliferator receptor alpha agonist · same classHigh cholesterol54 labelers$0.103 per tablet 160 mg tabletNoNo current entry
Fenofibric acidperoxisome proliferator receptor alpha agonist · same classHigh cholesterol7 labelers$0.286 per capsule 135 mg capsuleNoNo current entry
AtorvastatinHMG-CoA reductase inhibitorHeart attack and coronary artery disease, High cholesterol61 labelers$0.0228 per tablet 10 mg tabletNoNo current entry
RosuvastatinHMG-CoA reductase inhibitorHeart attack and coronary artery disease, High cholesterol46 labelers$0.0692 per tablet 40 mg tabletNoNo current entry
PravastatinHMG-CoA reductase inhibitorHeart attack and coronary artery disease, High cholesterol37 labelers$0.058 per tablet 20 mg tabletNoNo current entry
SimvastatinHMG-CoA reductase inhibitorHeart attack and coronary artery disease, High cholesterol27 labelers$0.0321 per tablet 20 mg tabletNoNo current entry
LovastatinHMG-CoA reductase inhibitorHeart attack and coronary artery disease, High cholesterol19 labelers$0.0436 per tablet 20 mg tabletNoNo current entry
PitavastatinHMG-CoA reductase inhibitorHigh cholesterol12 labelers$0.954 per tablet 2 mg tabletNoNo current entry
Ezetimibedietary cholesterol absorption inhibitorHigh cholesterol23 labelers$0.0667 per tablet 10 mg tabletNoNo current entry
Cholestyraminebile acid sequestrantHigh cholesterol15 labelers$0.834 per packet Cholestyramine packetNoNo current entry
Colesevelambile acid sequestrantHigh cholesterol15 labelers$0.262 per tablet 625 mg tabletNoNo current entry
Ezetimibe and simvastatindietary cholesterol absorption inhibitorHeart attack and coronary artery disease, High cholesterol7 labelers$0.285 per unit 10-80 mgNoNo current entry
Niacinnicotinic acidHeart attack and coronary artery disease, High cholesterol13 labelers$0.193 per tablet 500 mg tabletNoNo current entry
Colestipolbile acid sequestrantHigh cholesterol8 labelers$0.658 per tablet 1 g tabletNoNo current entry
FluvastatinHMG-CoA reductase inhibitorHigh cholesterol4 labelers$2.88 per tablet 80 mg tabletNoA presentation being discontinued
Lomitapidemicrosomal triglyceride transfer protein inhibitorHigh cholesterolnone listedn/aYesNo current entry
Bempedoic acidadenosine triphosphate-citrate lyase inhibitorHeart attack and coronary artery disease, High cholesterolnone listed$13.81 per tablet 180 mg tabletNoNo current entry
Bempedoic acid and ezetimibeadenosine triphosphate-citrate lyase inhibitorHeart attack and coronary artery disease, High cholesterolnone listed$13.80 per tablet 180-10 mg tabletNoNo current entry
EnlicitideHigh cholesterolnone listedn/aNoNo current entry

Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)

What do pharmacies pay for each?

The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What next?

Gemfibrozil: the full record
label, generics, price, shortages, recalls
Fenofibrate vs gemfibrozil
two records side by side
Gemfibrozil vs atorvastatin
two records side by side
Gemfibrozil vs rosuvastatin
two records side by side
Gemfibrozil vs simvastatin
two records side by side